Yahoo Finance: NMD Pharma late breaking oral presentation at the MDA Conference with top-line safety and efficacy data from SYNAPSE-CMT, an exploratory Phase 2a clinical study of ignaseclant ... NMD Pharma late breaking oral presentation at the MDA Conference with top-line safety and efficacy data from SYNAPSE-CMT, an exploratory Phase 2a clinical study of ignaseclant ... MSN: Alan Jackson, 67, Opens up About His CMT Symptoms: ‘It's Getting More Obvious' When legendary country singer Alan Jackson, 67, announced that the "finale" show of his farewell tour next year will support research to find a cure for Charcot-Marie-Tooth (CMT) disease, it shined a ...
Alan Jackson, 67, Opens up About His CMT Symptoms: ‘It's Getting More Obvious' BLACKSBURG, Va. – A Blacksburg woman with a rare disease hosted a walk on Saturday in hopes of raising awareness and finding others like her. Charcot-Marie-Tooth disease, or CMT, is a rare and ... Nasdaq: Applied Therapeutics Presents Positive 24-Month Data for Govorestat in CMT-SORD at PNS 2025 Annual Meeting Applied Therapeutics, Inc.
what is cmt illness, announced promising 18 and 24-month results from the INSPIRE Phase 2/3 trial of govorestat, a treatment for Charcot-Marie-Tooth Sorbitol Dehydrogenase Deficiency (CMT-SORD).
